​

Funding Round

Series A - Innoforce Pharmaceuticals

Series A - Innoforce Pharmaceuticals

Investment Firm

Overview

Innoforce is a biopharma manufacturing firm that facilitates the development and commercialization of innovative medicines.

Announced Date

Dec 06, 2021

Funding Type

Series A

Highlights

Location

Asia

Social

Investor Lead

South China Venture Capital

South China Venture Capital

South China Venture Capital is a early_stage_venture and private_equity firm.

Participant Investors

4

Investor Name
Participant InvestorChina Highrun Capital Limited
Participant InvestorSouth China Venture Capital
Participant InvestorCICC
Participant InvestorAdvantech Capital

Round Details and Background

Innoforce Pharmaceuticals raised $58811536 on 2021-12-06 in Series A

Innoforce is a biopharma manufacturing firm that facilitates the development and commercialization of innovative medicines.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 22, 2021
Series A - Innoforce Pharmaceuticals
2-96.0M
Dec 06, 2021
Series A - Innoforce Pharmaceuticals
9-58.8M

Recent Activity

There is no recent news or activity for this profile.